Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 75

1.

Neutrophils prime a long-lived effector macrophage phenotype that mediates accelerated helminth expulsion.

Chen F, Wu W, Millman A, Craft JF, Chen E, Patel N, Boucher JL, Urban JF Jr, Kim CC, Gause WC.

Nat Immunol. 2014 Oct;15(10):938-46. doi: 10.1038/ni.2984. Epub 2014 Aug 31.

PMID:
25173346
2.

Impact of GeneXpert MTB/RIF assay on triage of respiratory isolation rooms for inpatients with presumed tuberculosis: a hypothetical trial.

Chaisson LH, Roemer M, Cantu D, Haller B, Millman AJ, Cattamanchi A, Davis JL.

Clin Infect Dis. 2014 Nov 15;59(10):1353-60. doi: 10.1093/cid/ciu620. Epub 2014 Aug 4.

PMID:
25091300
3.

Surgeon-specific factors affecting treatment decisions among Canadian urologists in the management of pT1a renal tumours.

Millman AL, Pace KT, Ordon M, Lee JY.

Can Urol Assoc J. 2014 May;8(5-6):183-9. doi: 10.5489/cuaj.1884.

4.

A2B adenosine receptor induces protective antihelminth type 2 immune responses.

Patel N, Wu W, Mishra PK, Chen F, Millman A, Csóka B, Koscsó B, Eltzschig HK, Haskó G, Gause WC.

Cell Host Microbe. 2014 Mar 12;15(3):339-50. doi: 10.1016/j.chom.2014.02.001.

PMID:
24629340
5.

Rapid molecular testing for TB to guide respiratory isolation in the U.S.: a cost-benefit analysis.

Millman AJ, Dowdy DW, Miller CR, Brownell R, Metcalfe JZ, Cattamanchi A, Davis JL.

PLoS One. 2013 Nov 20;8(11):e79669. doi: 10.1371/journal.pone.0079669. eCollection 2013.

6.

An essential role for TH2-type responses in limiting acute tissue damage during experimental helminth infection.

Chen F, Liu Z, Wu W, Rozo C, Bowdridge S, Millman A, Van Rooijen N, Urban JF Jr, Wynn TA, Gause WC.

Nat Med. 2012 Jan 15;18(2):260-6. doi: 10.1038/nm.2628.

7.

Oxygen saturation as a predictor of adverse maternal outcomes in women with preeclampsia.

Millman AL, Payne B, Qu Z, Douglas MJ, Hutcheon JA, Lee T, Magee LA, Walley KR, von Dadelszen P.

J Obstet Gynaecol Can. 2011 Jul;33(7):705-14.

PMID:
21749746
8.

Prediction of adverse maternal outcomes in pre-eclampsia: development and validation of the fullPIERS model.

von Dadelszen P, Payne B, Li J, Ansermino JM, Broughton Pipkin F, Côté AM, Douglas MJ, Gruslin A, Hutcheon JA, Joseph KS, Kyle PM, Lee T, Loughna P, Menzies JM, Merialdi M, Millman AL, Moore MP, Moutquin JM, Ouellet AB, Smith GN, Walker JJ, Walley KR, Walters BN, Widmer M, Lee SK, Russell JA, Magee LA; PIERS Study Group.

Lancet. 2011 Jan 15;377(9761):219-27. doi: 10.1016/S0140-6736(10)61351-7. Epub 2010 Dec 23.

PMID:
21185591
9.

Impact of congenital anomalies and treatment location on the outcomes of infants hospitalized with herpes simplex virus (HSV).

Lorch SA, Millman AM, Shah SS.

J Hosp Med. 2010 Mar;5(3):154-9. doi: 10.1002/jhm.627.

PMID:
20235284
10.

Health services research doctoral core competencies.

Forrest CB, Martin DP, Holve E, Millman A.

BMC Health Serv Res. 2009 Jun 25;9:107. doi: 10.1186/1472-6963-9-107.

11.

Sealing the cracks, not falling through: using handoffs to improve patient care.

Paine LA, Millman A.

Front Health Serv Manage. 2009 Spring;25(3):33-8. No abstract available.

PMID:
19382515
12.

Time to send the preemie home? Additional maturity at discharge and subsequent health care costs and outcomes.

Silber JH, Lorch SA, Rosenbaum PR, Medoff-Cooper B, Bakewell-Sachs S, Millman A, Mi L, Even-Shoshan O, Escobar GJ.

Health Serv Res. 2009 Apr;44(2 Pt 1):444-63. doi: 10.1111/j.1475-6773.2008.00938.x. Epub 2008 Dec 31.

13.

Use of prolonged travel to improve pediatric risk-adjustment models.

Lorch SA, Silber JH, Even-Shoshan O, Millman A.

Health Serv Res. 2009 Apr;44(2 Pt 1):519-41. doi: 10.1111/j.1475-6773.2008.00940.x. Epub 2008 Dec 30.

14.

Air pollution threatens the health of children in China.

Millman A, Tang D, Perera FP.

Pediatrics. 2008 Sep;122(3):620-8. doi: 10.1542/peds.2007-3143. Review.

15.

Impact of admission-day crowding on the length of stay of pediatric hospitalizations.

Lorch SA, Millman AM, Zhang X, Even-Shoshan O, Silber JH.

Pediatrics. 2008 Apr;121(4):e718-30. doi: 10.1542/peds.2007-1280.

16.

Natural killer cells, glutathione, cytokines, and innate immunity against Mycobacterium tuberculosis.

Millman AC, Salman M, Dayaram YK, Connell ND, Venketaraman V.

J Interferon Cytokine Res. 2008 Mar;28(3):153-65. doi: 10.1089/jir.2007.0095.

PMID:
18338948
17.

Glutathione levels and immune responses in tuberculosis patients.

Venketaraman V, Millman A, Salman M, Swaminathan S, Goetz M, Lardizabal A, David Hom, Connell ND.

Microb Pathog. 2008 Mar;44(3):255-61. Epub 2007 Sep 26.

PMID:
17959342
18.

Using propensity scores subclassification to estimate effects of longitudinal treatments: an example using a new diabetes medication.

Segal JB, Griswold M, Achy-Brou A, Herbert R, Bass EB, Dy SM, Millman AE, Wu AW, Frangakis CE.

Med Care. 2007 Oct;45(10 Supl 2):S149-57.

PMID:
17909374
19.

Surgical treatment of capillary hemangiomas causing amblyopia.

Levi M, Schwartz S, Blei F, Ceisler E, Steele M, Furlan L, Millman A, Kodsi SR.

J AAPOS. 2007 Jun;11(3):230-4. Epub 2007 Mar 7.

PMID:
17344079
20.

Glutathione and growth inhibition of Mycobacterium tuberculosis in healthy and HIV infected subjects.

Venketaraman V, Rodgers T, Linares R, Reilly N, Swaminathan S, Hom D, Millman AC, Wallis R, Connell ND.

AIDS Res Ther. 2006 Feb 20;3:5.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk